PCLAF and diabetic retinopathy: Nevertheless, PAF seems to be a contributor to the pathological milieu of factors and processes in retinal diseases and perhaps PAF receptor antagonist can have a role in mitigating some signs and symptoms associated with diabetic retinopathy, ROP and age‐related macular degeneration (AMD).